HTRA2 Gene PARK13 Parkinson Genetic Test
At DNA Labs UAE, we offer the HTRA2 Gene PARK13 Parkinson Genetic Test for individuals who suspect they may have Parkinson’s disease. This test can help diagnose and provide valuable information for personalized treatment options.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the HTRA2 Gene PARK13 Parkinson Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by HTRA2 Gene PARK13 Parkinson.
Test Details
The HTRA2 gene is associated with the PARK13 subtype of Parkinson’s disease. This rare form of Parkinson’s disease is caused by mutations in the HTRA2 gene. The NGS (Next-Generation Sequencing) genetic testing method is used to analyze multiple genes simultaneously, including the HTRA2 gene. This test can identify any genetic variants or mutations in the HTRA2 gene that may be linked to Parkinson’s disease.
It is important to note that genetic testing alone cannot definitively diagnose Parkinson’s disease, as it is a complex condition with multiple contributing factors. A healthcare professional should make a diagnosis based on clinical symptoms and other diagnostic tests. However, the information obtained from the HTRA2 Gene PARK13 Parkinson Genetic Test can be useful for diagnosis, prognosis, and potentially for personalized treatment options.
For more information or to schedule an appointment for the HTRA2 Gene PARK13 Parkinson Genetic Test, please contact our Genetics Test Department and consult with a Neurologist.
Test Name | HTRA2 Gene PARK13 Parkinson Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for HTRA2 Gene PARK13 Parkinson NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with HTRA2 Gene PARK13 Parkinson |
Test Details |
The HTRA2 gene is associated with the PARK13 subtype of Parkinson’s disease. PARK13 is a rare form of Parkinson’s disease that is caused by mutations in the HTRA2 gene. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. It can identify mutations or variations in the HTRA2 gene that may be linked to Parkinson’s disease. By performing an NGS genetic test on the HTRA2 gene, individuals can determine if they carry any genetic variants that are associated with PARK13 Parkinson’s disease. This information can be useful for diagnosis, prognosis, and potentially for personalized treatment options. It is important to note that genetic testing alone cannot definitively diagnose Parkinson’s disease, as it is a complex condition with multiple contributing factors. A diagnosis should be made by a healthcare professional based on clinical symptoms and other diagnostic tests. |